Pure Global
NCT06256614

Washed Microbiota Transplantation for Type 1 Diabetes Mellitus

Washed Microbiota Transplantation for Type 1 Diabetes Mellitus: a Real World Research
The Second Hospital of Nanjing Medical University·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Type 1 Diabetes
Drug/Device/Intervention
WMT
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
The Second Hospital of Nanjing Medical University
Location
Nanjing, China
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
Jul 01, 2029
Enrollment
50 participants
Primary outcome

The Blood glucose of Time in Range (TIR, %) of type 1 diabetes mellitus.

Summary

This is a real-world study to explore the safety and the efficacy of washed microbiota
 transplantation (WMT) for patients with Type 1 Diabetes Mellitus (T1DM).

ICD-10 classifications
Type 1 diabetes mellitusType 1 diabetes mellitus without complicationsType 1 diabetes mellitus with unspecified complicationsType 1 diabetes mellitus with other specified complicationsType 1 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06256614
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06256614 through Pure Global AI's free database. This phase not specified trial is sponsored by The Second Hospital of Nanjing Medical University and is currently Recruiting. The study focuses on Type 1 Diabetes. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.